Glaucoma, Primary Open Angle
27
3
3
15
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
3.7%
1 terminated out of 27 trials
93.8%
+7.2% vs benchmark
19%
5 trials in Phase 3/4
40%
6 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (27)
Treating Psychosocial Distress in Glaucoma
Caffeine Consumption in Glaucoma Patients and Healthy Subjects
The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients
Excimer Laser Trabeculostomy Glaucoma Treatment Study
Safety and Feasibility of the ELIOS System in POAG Patients
Adaptive Optics Retinal Imaging
Safety and IOP-Lowering Effects of WB007
Effect of Peripapillary Atrophy to Diagnose Glaucoma in High Myopia
Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients
Glaucoma Assessment Via Reading Ability
Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert
The Effect of Topical Brimonidine on the Ocular Hemodynamics in Patients of POAG Using OCTA
Longitudinal Study on Glaucoma Surgery Using XEN® Gel Stent
Evaluation of Safety and Efficacy of TUG (Therapeutic Ultrasound for Glaucoma) in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension
Prospective, Single Center Switching Study of 0.0015% Tafluprost Ophthalmic Solution in Primary Open-angle Glaucoma and Ocular Hypertension Patients With Corneal Disorders (Switching From 0.005% Latanoprost Ophthalmic Solution)
Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
UCP (Ultrasound Cyclo Plasty) in the Treatment of Chinese Patients With Primary Open-angle Glaucoma
A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting
A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons
Assessment of Effectiveness Ex-Press Surgery Modification